Here is a meta-analysis questioning the success of various strategies aimed at addressing one of the biggest challenges to effective endocrine therapy in the management of breast cancer: poor adherence. Across 33 studies including nearly 400K women, a consistent loser was any strategy to educate patients about side effect management. On the other hand, any strategy to lower costs appeared victorious. | Bright, J Clin Oncol 2023
